Evidence map›Paper›PMID 22942787›Full record

ArticleComputing in science & engineering2012

Nanoinformatics: developing new computing applications for nanomedicine.

V Maojo, M Fritts, F Martin-Sanchez, D De la Iglesia, R E Cachau, M Garcia-Remesal, J Crespo, J A Mitchell, A Anguita, N Baker and 25 more

Abstract read
In one paragraph

Article in Computing in science & engineering, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Convergence of nanotechnology and cancer prevention: are we there yet?Cancer prevention research (Philadelphia, Pa.) · 2014
    Review
  5. Medical informatics in croatia - a historical survey.Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH · 2014
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors.

V MaojoBiomedical Informatics Group, Facultad de Informatica, Universidad Politecnica de Madrid, Spain.
M Fritts
F Martin-Sanchez
D De la Iglesia
R E Cachau
M Garcia-Remesal
J Crespo
J A Mitchell
A Anguita
N Baker
J M Barreiro
S E Benitez
G De la Calle
J C Facelli
P Ghazal
A Geissbuhler
F Gonzalez-Nilo
N Graf
P Grangeat
I Hermosilla
R Hussein
J Kern
S Koch
Y Legre
V Lopez-Alonso
G Lopez-Campos
L Milanesi
V Moustakis
C Munteanu
P Otero
A Pazos
D Perez-Rey
G Potamias
F Sanz
C Kulikowski

Funding

STANFORD COMPOSITE(RMI)U54HG004028 · NHGRI · STANFORD UNIVERSITY · PI MUSEN, MARK A · 2005 to 2014
$36.2M
Characterization/bioinformatics-modeling of nanoparticle:complement interactionsU01NS073457 · NINDS · WASHINGTON UNIVERSITY · PI HOURCADE, DENNIS EMIL · 2010 to 2012
$3.0M
NHGRI NIH HHS U54 HG004028NINDS NIH HHS U01 NS073457
6 · The paper itself

Abstract

Nanoinformatics has recently emerged to address the need of computing applications at the nano level. In this regard, the authors have participated in various initiatives to identify its concepts, foundations and challenges. While nanomaterials open up the possibility for developing new devices in many industrial and scientific areas, they also offer breakthrough perspectives for the prevention, diagnosis and treatment of diseases. In this paper, we analyze the different aspects of nanoinformatics and suggest five research topics to help catalyze new research and development in the area, particularly focused on nanomedicine. We also encompass the use of informatics to further the biological and clinical applications of basic research in nanoscience and nanotechnology, and the related concept of an extended "nanotype" to coalesce information related to nanoparticles. We suggest how nanoinformatics could accelerate developments in nanomedicine, similarly to what happened with the Human Genome and other -omics projects, on issues like exchanging modeling and simulation methods and tools, linking toxicity information to clinical and personal databases or developing new approaches for scientific ontologies, among many others.

Identifiers

PMID22942787
PMCPMC3430140

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.